Virax Biolabs Files 6-K for February 2025
Ticker: VRAX · Form: 6-K · Filed: Feb 25, 2025 · CIK: 1885827
| Field | Detail |
|---|---|
| Company | Virax Biolabs Group Ltd (VRAX) |
| Form Type | 6-K |
| Filed Date | Feb 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K, corporate-filing, foreign-private-issuer
TL;DR
Virax Biolabs Group Ltd filed a 6-K on Feb 25, 2025, with routine corporate updates.
AI Summary
Virax Biolabs Group Ltd filed a Form 6-K on February 25, 2025, reporting information for the month of February 2025. The company, previously known as Virax Biolabs (Cayman) Ltd until September 30, 2021, is incorporated in E9 with a fiscal year end of March 31. Its principal executive offices are located in Lanarkshire, United Kingdom.
Why It Matters
This filing provides routine updates and information for investors regarding Virax Biolabs Group Ltd's operations and corporate status.
Risk Assessment
Risk Level: low — This filing is a standard 6-K report, typically containing routine corporate information and not indicating significant new risks.
Key Players & Entities
- Virax Biolabs Group Ltd (company) — Registrant
- Virax Biolabs (Cayman) Ltd (company) — Former company name
- February 25, 2025 (date) — Filing date
- 20250225 (date) — Report date
- 001-41440 (other) — SEC File Number
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers filed with the SEC pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to provide information that the company makes or is required to make public in its home country, files with a stock exchange, or distributes to its security holders.
When was Virax Biolabs Group Ltd's name changed?
The company's name was changed from Virax Biolabs (Cayman) Ltd on September 30, 2021.
What is the fiscal year end for Virax Biolabs Group Ltd?
The fiscal year end for Virax Biolabs Group Ltd is March 31.
Where are Virax Biolabs Group Ltd's principal executive offices located?
The principal executive offices of Virax Biolabs Group Ltd are located at BioCity Glasgow, Bo'Ness Road, Newhouse, Lanarkshire, ML1 5UH, United Kingdom.
What is the SEC file number for Virax Biolabs Group Ltd?
The SEC file number for Virax Biolabs Group Ltd is 001-41440.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on February 25, 2025 regarding Virax Biolabs Group Ltd (VRAX).